Aquestive Therapeutics Inc (AQST)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -60.646 | -27.69 | -94.449 | -80.138 | -78.922 | -112.974 | -91.397 | -13.748 |
Return on Equity (%) | 41.764 | 18.162 | 209.775 | -3347.448 | 204.262 | 107.997 | 54.223 | 6.994 |
Return on Invested Capital (%) | -7.787 | -0.324 | -139.237 | -98.928 | -268.383 | 116.413 | 67.636 | 17.717 |
Operating Margin (%) | -6.68 | -1.847 | -79.586 | -108.21 | -93.265 | -94.582 | -88.018 | -0.322 |
Net Profit Margin (%) | -23.065 | -17.07 | -91.022 | -125.921 | -121.667 | -138.769 | -114.115 | -15.559 |
Book Value Per Share | -0.114 | -0.168 | 0.053 | -0.032 | -0.25 | -0.72 | -0.939 | -0.771 |
Earnings Per Share | -0.076 | -0.072 | -0.332 | -0.343 | -0.287 | -0.618 | -0.426 | -0.056 |
Cash Per Share | 0.059 | 0.109 | 0.328 | 0.255 | 0.164 | 0.245 | 0.213 | 0.171 |
Working Capital Per Share | 0.08 | 0.08 | 0.223 | 0.258 | 0.121 | 0.221 | 0.042 | 0.162 |
Operating Profit Per Share | 0.25 | 0.319 | 0.269 | 0.182 | 0.187 | 0.34 | 0.24 | 0.223 |
EBIT Per Share | -0.061 | -0.056 | -0.332 | -0.343 | -0.287 | -0.618 | -0.426 | -0.055 |
EBITDA Per Share | -0.061 | -0.056 | -0.332 | -0.343 | -0.287 | -0.618 | -0.426 | -0.055 |
Free Cash Flow Per Share | -0.095 | -0.082 | -0.34 | -0.354 | -0.302 | -0.636 | -0.425 | -0.059 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | 24,96M | 33,56M | 34,57M | 41,23M | 54,83M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 53,85M | 54,83M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | 85.818 | N/A | N/A | N/A | -71.584 | N/A |
Net Profit Margin (%) | N/A | N/A | 72.463 | N/A | N/A | N/A | -106.43 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 404,83M |
Ratio cours/bénéfice | -53,77 |
Ratio prix/ventes | 8,36 |
Ratio prix/liquidités | 17,72 |
Ratio prix/valeur comptable | -3,97 |
Rendement de dividende | - |
Actions en circulation | 91,18M |
Volume moyen (1 semaine) | 1,78M |
Volume moyen (1 mois) | 1,73M |
Variation sur 52 semaines | 162,29% |
Plus haut sur 52 semaines | 6,23 |
Plus bas sur 52 semaines | 1,73 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales